Product Details
Place of Origin: China
Brand Name: Sunshine
Certification: ISO,COA
Model Number: 122892-31-3
Payment & Shipping Terms
Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: Bag,Drum
Delivery Time: 7-15 days
Payment Terms: L/C, D/A, T/T, Western Union
Supply Ability: TON
CAS NO:: |
122892-31-3 |
Appearance:: |
White Or Pale Brownish Crystal |
Molecular Formula:: |
C20H27ClN2O4 |
Molecular Weight:: |
394.89200 |
EINECS NO:: |
602-905-1 |
MDL NO:: |
MFCD00881710 |
CAS NO:: |
122892-31-3 |
Appearance:: |
White Or Pale Brownish Crystal |
Molecular Formula:: |
C20H27ClN2O4 |
Molecular Weight:: |
394.89200 |
EINECS NO:: |
602-905-1 |
MDL NO:: |
MFCD00881710 |
Product Description:
Product Name: Itopride hydrochloride CAS NO: 122892-31-3
Synonyms:
N-[4-[2-(Dimethylamino)ethoxy]benzyl]-3,4-dimetho-xybenzamide Hydrochloride;
N-(p-(2-(Dimethylamino)ethoxy)benzyl)veratramide Hydrochloride;
Benzamide, N-[[4-[2-(dimethylamino)ethoxy]phenyl]methyl]-3,4-dimetho-xy-, hydrochloride (1:1);
Chemical & Physical Properties:
Appearance: white or pale brownish crystal
Assay :≥99.0%
Boiling Point: 510.1℃ at 760 mmHg
Melting Point: 194-1950℃
Flash Point: 262.3℃
Vapor Pressure: 1.6E-10mmHg at 25℃
Safety Information:
HS Code: 2924299090
Caution Statement: P273; P501
Symbol: GHS09
Hazard Declaration: H410
Signal Word: Warning
Dopamine D2-receptor antagonist with anticholinesterase activity. Gastroprokinetic. Itopride hydrochloride is an AChE inhibitor (acetylcholinesterase) and D2DR inhibitor.Target: AChEItopride is a gastroprokinetic benzamide derivative. The IC50 of itopride with AChE (2.04 +/- 0.27 microM) was, however, 100-fold less than that with BuChE, whereas in the case of neostigmine with AChE (11.3 +/- 3.4 nM), it was 10-fold less. The inhibitory effect of itopride on cholinesterase (ChE) activity in guinea pig gastrointestine was much weaker than that on pure AChE. the IC50s of itopride against ChE activities were found to be about 0.5 microM. The IC50 of itopride for electric eel and guinea pig gastrointestinal AChE inhibition was 200 times and 50 times as large as that of neostigmine, respectively [1].
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.